What is a fair comparison in head-to-head trials of antiepileptic drugs?

The Lancet Neurology

Volumn 10, Issue 10, 2011, Pages 866-867

  French, Jacqueline ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; PREGABALIN; TOPIRAMATE; VIGABATRIN;

ADD ON THERAPY; DRUG APPROVAL; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; EPILEPSY; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; LETTER; PRIORITY JOURNAL; REMISSION; TREATMENT RESPONSE;

ANTICONVULSANTS; EPILEPSIES, PARTIAL; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; TRIAZINES;

EID: 80052962453     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(11)70191-0     Document Type: Letter

References (10)

1. Kwan P, Brodie MJ, Kälviäinen R, Yurkewicz L, Weaver J, Knapp LE Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial. Lancet Neurol 2011, published online Sept 1. 10.1016/S1474-4422(11)70154-5.
2. Ryvlin P Defining success in clinical trials-profiling pregabalin, the newest AED. Eur J Neurol 2005, 12(suppl 4):12-21.
3. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004, 62:1252-1260.
4. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004, 62:1261-1273.
5. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007, 369:1000-1015. on behalf of the SANAD Study group.
6. Glauser T, Ben-Menachem E, Bourgeois B, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006, 47:1094-1120.
7. Marson AG, Kadir ZA, Chadwick DW New antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ 1996, 313:1169-1174.
8. Gamble CL, Williamson PR, Marson AG Lamotrigine versus carbamazepine monotherapy for epilepsy. Cochrane Database Syst Rev 2006, 1. CD001031.
9. French JA First-choice drug for newly diagnosed epilepsy. Lancet 2007, 369:970-971.
10. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010, 51:1069-1077.